Designing Combinational Circuitry - Circuit Cellar circuitcellar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from circuitcellar.com Daily Mail and Mail on Sunday newspapers.
Aptose Tuspetinib Clinical Data Selected for Oral Presentation at the 2023 ASH Annual Meeting itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
02:59 PM
The Office of the National Coordinator for Health IT this week launched its new Synthetic Health Data Challenge – offering researchers a chance to explore new avenues of medical research.
WHY IT MATTERS
Participants are invited to develop and test innovative new tools and approaches to build on the capabilities of Synthea, an open-source synthetic patient generator that models the medical histories of synthetic patients.
The goal is to advance research and development and to validate the realism of synthetic health records generated by Synthea, according to ONC – creating or improving disease-progression and treatment modules used to create synthetic records, and driving innovative new uses of synthetic health data.
MindMed Will Use the Proceeds of the Offering for Investment in its Digital Medicine Division, for Further Investments in its Project Lucy and Project Layla, for its LSD Micro-Dosing ADHD Trials and for General Working Capital Purposes
MindMed (OTCQB:MMEDF) announced that further to its previously announced offering on December 14 and December 15, 2020, it has filed a preliminary short form prospectus with the securities commissions or similar authorities in each province of Canada, other than Québec. Pursuant to the underwriting agreement among the company, the underwriters Canaccord Genuity and Eight Capital have agreed to purchase 18,200,000 units of the company, on a bought deal basis, at a price per unit of CDN $4.40 for gross proceeds of CDN $80.08 million.